Australian Broker Call

Produced and copyrighted by at www.fnarena.com

September 25, 2024

Access Broker Call Report Archives here

COMPANIES DISCUSSED IN THIS ISSUE

Click on symbol for fast access.

The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).

Last Updated: 05:00 PM

Your daily news report on the latest recommendation, valuation, forecast and opinion changes.

This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.

For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE

ADT  ADRIATIC METALS PLC

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.52

Morgans rates ADT as Add (1) -

The operational update by Adriatic Metals was better-than-feared by Morgans as the Vares (silver-lead-zinc) project in Bosnia steadily ramps-up toward full capacity in early-2025.

While management trimmed 2024 ore production guidance, 2025 production guidance was reaffirmed offering good comfort for investors, suggests the analyst.

While costs are trending around 20% above definitive feasibility study (DFS) expectations, they are in line with the broker's expectations, and support first quartile, high-margin cash flows at full production.

The target falls to $5.30 from $5.80. Add.

Target price is $5.30 Current Price is $3.52 Difference: $1.78
If ADT meets the Morgans target it will return approximately 51% (excluding dividends, fees and charges).

The company's fiscal year ends in December.

Forecast for FY24:

Morgans forecasts a full year FY24 dividend of 0.00 cents and EPS of minus 11.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is minus 32.00.

Forecast for FY25:

Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.62 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 567.74.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CCR  CREDIT CLEAR LIMITED

Diversified Financials

More Research Tools In Stock Analysis - click HERE

Overnight Price: $0.28

Shaw and Partners rates CCR as Buy (1) -

Shaw and Partners draws the comparison between the current valuation ascribed to Credit Clear against an unlisted peer which obtained $60m in capital, valuing the company at 7 times run-rate sales or $350m.

The broker emphasises Credit Clear is valued at $110m enterprise value of 2x sales and attributes the difference to the unlisted company because it is a debt collection partner of a buy-now-pay-later business with around $50m in US sales.

Shaw and Partners believes Credit Clear has scope to double its market share in Australia to 20%, generating FY30 revenues of $120m versus FY25 guidance of $50m.

Buy rating. High risk and 44c target price unchanged.

Target price is $0.44 Current Price is $0.28 Difference: $0.155
If CCR meets the Shaw and Partners target it will return approximately 54% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY25:

Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 142.50.

Forecast for FY26:

Shaw and Partners forecasts a full year FY26 dividend of 0.00 cents and EPS of 0.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 47.50.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CHC  CHARTER HALL GROUP

REITs

More Research Tools In Stock Analysis - click HERE

Overnight Price: $16.12

Morgan Stanley rates CHC as Overweight (1) -

Morgan Stanley reverses bearish assumptions previously applied to forecasts for Charter Hall and now expects further share price upside over the next 12-18 months due to ongoing global interest rate cuts.

Overweight rating. The target rises to $18.50 from $15.80. Industry view: In-Line. 

The analysts believe the current PE multiple of 20x times is more than justified and alters favourably the blend of Bull/Bear/Base case scenarios for the stock. The broker's earnings forecasts are unchanged.

Target price is $18.50 Current Price is $16.12 Difference: $2.38
If CHC meets the Morgan Stanley target it will return approximately 15% (excluding dividends, fees and charges).

Current consensus price target is $15.16, suggesting downside of -4.7% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Morgan Stanley forecasts a full year FY25 dividend of 47.80 cents and EPS of 79.00 cents.
At the last closing share price the estimated dividend yield is 2.97%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 20.41.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 79.7, implying annual growth of N/A.

Current consensus DPS estimate is 47.9, implying a prospective dividend yield of 3.0%.

Current consensus EPS estimate suggests the PER is 20.0.

Forecast for FY26:

Morgan Stanley forecasts a full year FY26 dividend of 50.60 cents and EPS of 83.10 cents.
At the last closing share price the estimated dividend yield is 3.14%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 19.40.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 84.8, implying annual growth of 6.4%.

Current consensus DPS estimate is 50.8, implying a prospective dividend yield of 3.2%.

Current consensus EPS estimate suggests the PER is 18.8.

Market Sentiment: 0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

CYL  CATALYST METALS LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.83

Morgans rates CYL as Add (1) -

As the gold price remains near all-time highs, Morgans expects capital will flow to mid-cap producers and developers, as well as to advanced exploration projects.

The analyst highlights mid-cap miners like Catalyst Metals and Regis Resources have underperformed the gold price
index by -30% since mid-2022.

Over the same period, senior producers such as Northern Star Resources ((NST)) have fared better with around -8% underperformance.

The Add rating (Speculative) and $1.32 target are retained for Catalyst Metals.

Target price is $1.32 Current Price is $2.83 Difference: minus $1.51 (current price is over target).
If CYL meets the Morgans target it will return approximately minus 53% (excluding dividends, fees and charges - negative figures indicate an expected loss).

The company's fiscal year ends in June.

Forecast for FY25:

Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.06 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 4716.67.

Forecast for FY26:

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

FBU  FLETCHER BUILDING LIMITED

Building Products & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.72

UBS rates FBU as Neutral (3) -

Fletcher Building announced a NZ$700m capital raise including an institutional placement of NZ$282m and a NZ$418m rights issue at NZ$2.40.

UBS believes the raising is pre-emptive to remove any risks around debt covenant breaches while alleviating pressure to divest assets at discounted prices.

Management's trading update for July/August met the broker's expectations and guidance.

UBS suggests the company might be approaching the bottom of the cycle as the balance sheet is de-geared and lower interest rates support consumer and business confidence.

Target price of NZ$3.45 (post equity raising NZ$3.16) with a Neutral rating maintained.

Current Price is $2.72. Target price not assessed.

Current consensus price target is $2.48, suggesting downside of -8.8% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

UBS forecasts a full year FY25 dividend of 0.00 cents and EPS of 16.60 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.38.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 16.3, implying annual growth of N/A.

Current consensus DPS estimate is 0.9, implying a prospective dividend yield of 0.3%.

Current consensus EPS estimate suggests the PER is 16.7.

Forecast for FY26:

UBS forecasts a full year FY26 dividend of 0.00 cents and EPS of 27.67 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 9.83.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 24.6, implying annual growth of 50.9%.

Current consensus DPS estimate is 4.2, implying a prospective dividend yield of 1.5%.

Current consensus EPS estimate suggests the PER is 11.1.

This company reports in NZD. All estimates have been converted into AUD by FNArena at present FX values.

Market Sentiment: -0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

HLS  HEALIUS LIMITED

Healthcare services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $1.70

Morgans rates HLS as Hold (3) -

Healius has sold Lumus Imaging to Affinity Equity Partners for $965m creating a simpler, well-capitalised operating structure, highlights Morgans.

Sale proceeds will help refinance and right-size debt facilities, explains the broker, with management intending to “prioritise the distribution of surplus proceeds to shareholders in a tax efficient manner”.

Morgans cautions broad-based structural change continues, making translation into sustainable earnings growth both challenging and difficult to predict.

Hold rating maintained and target is increased to $1.53 from $1.48.

Target price is $1.53 Current Price is $1.70 Difference: minus $0.165 (current price is over target).
If HLS meets the Morgans target it will return approximately minus 10% (excluding dividends, fees and charges - negative figures indicate an expected loss).

Current consensus price target is $1.50, suggesting downside of -11.2% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Morgans forecasts a full year FY25 dividend of 3.00 cents and EPS of 3.70 cents.
At the last closing share price the estimated dividend yield is 1.77%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 45.81.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 3.1, implying annual growth of N/A.

Current consensus DPS estimate is 1.5, implying a prospective dividend yield of 0.9%.

Current consensus EPS estimate suggests the PER is 54.5.

Forecast for FY26:

Morgans forecasts a full year FY26 dividend of 4.00 cents and EPS of 6.00 cents.
At the last closing share price the estimated dividend yield is 2.36%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.25.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 5.8, implying annual growth of 87.1%.

Current consensus DPS estimate is 3.5, implying a prospective dividend yield of 2.1%.

Current consensus EPS estimate suggests the PER is 29.1.

Market Sentiment: -0.5

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

IDX  INTEGRAL DIAGNOSTICS LIMITED

Medical Equipment & Devices

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.77

Ord Minnett rates IDX as Buy (1) -

Ord Minnett notes the Scheme Booklet for the Integral Diagnostics, Capitol Health ((CAJ)) deal has been released.

Post the announcement of Healius' ((HLS)) sale of Lumus imaging, the analyst stresses the disconnect in pricing between the public market's valuation on Integral Diagnostics versus the private market on Lumus.

Buy rating with Ord Minnett expecting the stock to re-rate over time. Target rises to $3.30 from $3.

Target price is $3.30 Current Price is $2.77 Difference: $0.53
If IDX meets the Ord Minnett target it will return approximately 19% (excluding dividends, fees and charges).

The company's fiscal year ends in June.

Forecast for FY25:

Ord Minnett forecasts a full year FY25 dividend of 9.10 cents and EPS of 11.60 cents.
At the last closing share price the estimated dividend yield is 3.29%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 23.88.

Forecast for FY26:

Ord Minnett forecasts a full year FY26 dividend of 11.70 cents and EPS of 16.50 cents.
At the last closing share price the estimated dividend yield is 4.22%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 16.79.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

JLG  JOHNS LYNG GROUP LIMITED

Building Products & Services

More Research Tools In Stock Analysis - click HERE

Overnight Price: $3.60

Morgan Stanley rates JLG as Overweight (1) -

In addition to FY25 guidance, management at Johns Lyng now expects further revenue and earnings (EBITDA) of $100m and $9m, respectively, after announcing the acquisition of Keystone Financial Strategists.

Johns Lyng will pay -$47.7m up-front ($44.1m cash and $3.6m equity) for 87.5% of Keystone, and a further -$21.4m earn-out on FY25/ FY26 earnings thresholds.

The Overweight rating and $4.40 target are maintained. Industry view: In-Line.

Target price is $4.40 Current Price is $3.60 Difference: $0.8
If JLG meets the Morgan Stanley target it will return approximately 22% (excluding dividends, fees and charges).

Current consensus price target is $4.63, suggesting upside of 25.5% (ex-dividends)

The company's fiscal year ends in June.

Forecast for FY25:

Morgan Stanley forecasts a full year FY25 dividend of 7.90 cents and EPS of 16.90 cents.
At the last closing share price the estimated dividend yield is 2.19%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 21.30.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 17.6, implying annual growth of 1.5%.

Current consensus DPS estimate is 8.7, implying a prospective dividend yield of 2.4%.

Current consensus EPS estimate suggests the PER is 21.0.

Forecast for FY26:

Morgan Stanley forecasts a full year FY26 dividend of 8.90 cents and EPS of 19.00 cents.
At the last closing share price the estimated dividend yield is 2.47%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 18.95.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 20.0, implying annual growth of 13.6%.

Current consensus DPS estimate is 9.5, implying a prospective dividend yield of 2.6%.

Current consensus EPS estimate suggests the PER is 18.5.

Market Sentiment: 0.6

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

LNW  LIGHT & WONDER INC

Gaming

More Research Tools In Stock Analysis - click HERE

Overnight Price: $134.53

Bell Potter rates LNW as Buy (1) -

Bell Potter considers the US District Court for Nevada's decision granting Aristocrat Leisure ((ALL)) a preliminary injunction relating to Light & Wonder's Dragon Game as disappointing.

The analyst highlights a report from Aristocrat where the court stated Light & Wonder must refrain from "any continued or planned sale, leasing or other commercialisation of Dragon Train' stopping further installation of the product in its installed base and sales globally.

Bell Potter understands the current installed base can use it, but the company might be at risk of damages payments. The analyst's EPS forecasts are cut by -5% in FY24 and -10% in FY25.

No change to Buy rating. Target price reduced to $161 from $186.

Target price is $161.00 Current Price is $134.53 Difference: $26.47
If LNW meets the Bell Potter target it will return approximately 20% (excluding dividends, fees and charges).

Current consensus price target is $172.40, suggesting upside of 29.9% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Bell Potter forecasts a full year FY24 dividend of 0.00 cents and EPS of 419.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 32.05.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 449.9, implying annual growth of 66.7%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 29.5.

Forecast for FY25:

Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of 496.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 27.10.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 603.8, implying annual growth of 34.2%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 22.0.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Ord Minnett rates LNW as Accumulate (2) -

Ord Minnett notes Light & Wonder has been stopped from the "continued or planned sale, leasing or other commercialisation" of Dragon Train post a preliminary injunction from Aristocrat Leisure ((ALL)) by the US District Court of Nevada.

Aristocrat may pursue legal action in Australia while it will also continue to consider and "seek all appropriate remedies" against Light & Wonder.

Ord Minnett lowers EPS forecasts by -1% for 2024 and -4% for 2025. Target price falls to $166 from $176. Accumulate rating unchanged.

Target price is $166.00 Current Price is $134.53 Difference: $31.47
If LNW meets the Ord Minnett target it will return approximately 23% (excluding dividends, fees and charges).

Current consensus price target is $172.40, suggesting upside of 29.9% (ex-dividends)

The company's fiscal year ends in December.

Forecast for FY24:

Current consensus EPS estimate is 449.9, implying annual growth of 66.7%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 29.5.

Forecast for FY25:

Current consensus EPS estimate is 603.8, implying annual growth of 34.2%.

Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.

Current consensus EPS estimate suggests the PER is 22.0.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

RRL  REGIS RESOURCES LIMITED

Gold & Silver

More Research Tools In Stock Analysis - click HERE

Overnight Price: $2.00

Morgans rates RRL as Add (1) -

As the gold price remains near all-time highs, Morgans expects capital will flow to mid-cap producers and developers, as well as to advanced exploration projects.

The analyst highlights mid-cap miners like Catalyst Metals and Regis Resources have underperformed the gold price
index by -30% since mid-2022.

Over the same period, senior producers such as Northern Star Resources ((NST)) have fared better with around -8% underperformance.

The Add rating and $2.01 target are retained for Regis Resources.

Regis Resources remains Morgans top pick from stocks under coverage in the Gold sector with positive upcoming catalysts for  McPhillamys and the rolling-off of a lower-price hedge book in FY24. The company also trades at a cheaper valuation than peers.

The Add rating and $2.01 target are retained.

Target price is $2.01 Current Price is $2.00 Difference: $0.01
If RRL meets the Morgans target it will return approximately 0% (excluding dividends, fees and charges).

Current consensus price target is $1.99, suggesting upside of 0.0% (ex-dividends)

Forecast for FY25:

Current consensus EPS estimate is 21.8, implying annual growth of N/A.

Current consensus DPS estimate is 1.5, implying a prospective dividend yield of 0.8%.

Current consensus EPS estimate suggests the PER is 9.1.

Forecast for FY26:

Current consensus EPS estimate is 22.0, implying annual growth of 0.9%.

Current consensus DPS estimate is 3.6, implying a prospective dividend yield of 1.8%.

Current consensus EPS estimate suggests the PER is 9.0.

Market Sentiment: 0.3

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

TUA  TUAS LIMITED

Telecommunication

More Research Tools In Stock Analysis - click HERE

Overnight Price: $4.81

Citi rates TUA as Buy (1) -

After further analysis of yesterday's FY24 result, Citi raises its target for Tuas to $5.55 from $5.25 and retains a Buy rating.

Summary of the broker's initial response on results day:

Citi's initial assessment of today's FY24 result for Tuas is that Broadband has gained solid traction, and the Mobile result was ahead of expectation. Compared to the broker's forecasts, revenue and earnings (EBITA) were beats of 5.5% and 13%, respectively.

Shares are expected to trade higher today given these strong beats and higher-than-expected subscriber growth in both Mobile (9% beat against the broker's forecast) and Broadband (more than 4,000; 1,200 forecast).

The analyst highlights early encouraging evidence of 10Gbps broadband take-up in the residential market. Despite the ramp-up associated with Broadband, the mid-point of capex guidance is only 4% ahead of FY24 capex of -$48m, notes Citi.

Target price is $5.55 Current Price is $4.81 Difference: $0.74
If TUA meets the Citi target it will return approximately 15% (excluding dividends, fees and charges).

The company's fiscal year ends in August.

Forecast for FY25:

Citi forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.50 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 962.00.

Forecast for FY26:

Citi forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.30 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 209.13.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgan Stanley rates TUA as Overweight (1) -

FY24 earnings (EBITDA) for Tuas beat Morgan Stanley's forecast by 12% underpinned by mobile subscriber growth and margin expansion. It's felt the company is well positioned to continue disrupting the Singapore telco market.

The company added 234,000 subscribers to reach 1,053,000 in total, when the analysts were expecting a slowing, and management is aiming for more "broad-based" mobile subscriber growth in FY25.

In the only concern noted by the broker, first time FY25 capex was 9% higher-than-expected.

The target rises to $5.50 from $4.30. Overweight. Industry view is In-Line.

Target price is $5.50 Current Price is $4.81 Difference: $0.69
If TUA meets the Morgan Stanley target it will return approximately 14% (excluding dividends, fees and charges).

The company's fiscal year ends in August.

Forecast for FY25:

Morgan Stanley forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.16 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 3006.25.

Forecast for FY26:

Morgan Stanley forecasts a full year FY26 dividend of 0.00 cents and EPS of 2.12 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 226.89.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WEB  WEBJET LIMITED

Travel, Leisure & Tourism

More Research Tools In Stock Analysis - click HERE

Overnight Price: $7.15

Citi rates WEB as Buy (1) -

Following the demerger, and a trading update by management at Webjet (soon-to-be-called Web Travel Group), Citi launches a new set of financials for the stand alone B2B business (excluding B2C).

The broker sets an $8.25 target for the standalone B2B business and remains cautiously optimistic with a Buy rating.

The recent share price slide appears to be a reaction to slowing growth expectations, but the analysts are optimistic about a re-acceleration in August total transaction value (TTV).

Target price is $8.25 Current Price is $7.15 Difference: $1.1
If WEB meets the Citi target it will return approximately 15% (excluding dividends, fees and charges).

Current consensus price target is $8.99, suggesting upside of 25.9% (ex-dividends)

The company's fiscal year ends in March.

Forecast for FY25:

Citi forecasts a full year FY25 dividend of 0.00 cents and EPS of 25.20 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 28.37.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.3, implying annual growth of 71.1%.

Current consensus DPS estimate is 6.0, implying a prospective dividend yield of 0.8%.

Current consensus EPS estimate suggests the PER is 22.1.

Forecast for FY26:

Citi forecasts a full year FY26 dividend of 0.00 cents and EPS of 31.70 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.56.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 40.3, implying annual growth of 24.8%.

Current consensus DPS estimate is 7.5, implying a prospective dividend yield of 1.1%.

Current consensus EPS estimate suggests the PER is 17.7.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources


Morgans rates WEB as Add (1) -

Webjet, soon-to-be-called Web Travel Group, now centres around WebBeds -the global B2B travel marketplace- which has big growth ambitions over coming years, observes Morgans.

The broker maintains an Add rating with a new target of $8.60, down from $11.20 for the two businesses combined. Management has a strong track record of winning market share and this trend is expected to continue. 

The analysts are anticipating a subdued 1H result after the recent weaker-than-expected trading update and lower revenue margin guidance.

Target price is $8.60 Current Price is $7.15 Difference: $1.45
If WEB meets the Morgans target it will return approximately 20% (excluding dividends, fees and charges).

Current consensus price target is $8.99, suggesting upside of 25.9% (ex-dividends)

The company's fiscal year ends in March.

Forecast for FY25:

Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 24.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 29.79.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 32.3, implying annual growth of 71.1%.

Current consensus DPS estimate is 6.0, implying a prospective dividend yield of 0.8%.

Current consensus EPS estimate suggests the PER is 22.1.

Forecast for FY26:

Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of 32.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 22.34.

How do these forecasts compare to market consensus projections?

Current consensus EPS estimate is 40.3, implying annual growth of 24.8%.

Current consensus DPS estimate is 7.5, implying a prospective dividend yield of 1.1%.

Current consensus EPS estimate suggests the PER is 17.7.

Market Sentiment: 0.7

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

WJL  WEBJET GROUP LIMITED

More Research Tools In Stock Analysis - click HERE

Morgans rates WJL as Initiation of coverage with Add (1) -

Having being spun out of Webjet (soon-to-be-called Web Travel Group), Webjet Group comprises Webjet OTA -A&NZ's leading online travel agency- and GoSee, which is a travel e-commerce group that specialises in global car and motorhome rentals, explains Morgans.

Webjet Group also owns Trip Ninja which is technology that automates complex international travel itineraries.

Research coverage by the broker is initiated with an Add rating and 95c target.

While the business is mature and relatively low growth, notes the analyst, it is a market leader with a well-recognised brand, a track record of technology innovation, high margins and generating strong cashflow.

Target price is $0.95

The company's fiscal year ends in March.

Forecast for FY25:

Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of 5.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 0.00.

Forecast for FY26:

Morgans forecasts a full year FY26 dividend of 3.00 cents and EPS of 6.00 cents.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 0.00.

Market Sentiment: 1.0

All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources

Today's Price Target Changes
Company Last Price Broker New Target Prev Target Change
ADT Adriatic Metals $3.47 Morgans 5.30 5.80 -8.62%
CHC Charter Hall $15.91 Morgan Stanley 18.50 15.80 17.09%
HLS Healius $1.69 Morgans 1.53 1.48 3.38%
IDX Integral Diagnostics $2.82 Ord Minnett 3.30 3.00 10.00%
LNW Light & Wonder $132.75 Bell Potter 161.00 186.00 -13.44%
Ord Minnett 166.00 178.00 -6.74%
TUA Tuas $4.77 Citi 5.55 5.25 5.71%
Morgan Stanley 5.50 4.30 27.91%
VCX Vicinity Centres $2.25 Morgan Stanley 2.25 2.17 3.69%
WEB Webjet $7.14 Citi 8.25 10.70 -22.90%
Morgans 8.60 11.20 -23.21%
Summaries
ADT Adriatic Metals Add - Morgans Overnight Price $3.52
CCR Credit Clear Buy - Shaw and Partners Overnight Price $0.28
CHC Charter Hall Overweight - Morgan Stanley Overnight Price $16.12
CYL Catalyst Metals Add - Morgans Overnight Price $2.83
FBU Fletcher Building Neutral - UBS Overnight Price $2.72
HLS Healius Hold - Morgans Overnight Price $1.70
IDX Integral Diagnostics Buy - Ord Minnett Overnight Price $2.77
JLG Johns Lyng Overweight - Morgan Stanley Overnight Price $3.60
LNW Light & Wonder Buy - Bell Potter Overnight Price $134.53
Accumulate - Ord Minnett Overnight Price $134.53
RRL Regis Resources Add - Morgans Overnight Price $2.00
TUA Tuas Buy - Citi Overnight Price $4.81
Overweight - Morgan Stanley Overnight Price $4.81
WEB Webjet Buy - Citi Overnight Price $7.15
Add - Morgans Overnight Price $7.15
WJL Webjet Group Initiation of coverage with Add - Morgans Overnight Price $0.00
RATING SUMMARY
Rating No. Of Recommendations
1. Buy

13

2. Accumulate

1

3. Hold

2

Wednesday 25 September 2024

Access Broker Call Report Archives here

Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don't have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface. This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.